23.14
前日終値:
$23.05
開ける:
$22.43
24時間の取引高:
3.05M
Relative Volume:
1.20
時価総額:
$2.96B
収益:
$631.73M
当期純損益:
$-239.78M
株価収益率:
-11.46
EPS:
-2.02
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
+22.50%
1か月 パフォーマンス:
+15.99%
6か月 パフォーマンス:
+73.07%
1年 パフォーマンス:
+116.46%
10 X Genomics Inc Stock (TXG) Company Profile
名前
10 X Genomics Inc
セクター
電話
(925) 401-7300
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, TEM, BTSG, HQY, WAY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TXG
10 X Genomics Inc
|
23.14 | 2.94B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
181.45 | 29.92B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.31 | 9.52B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
41.58 | 7.47B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
77.93 | 6.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.25 | 4.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-12-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | 開始されました | Piper Sandler | Neutral |
| 2025-02-13 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 開始されました | Leerink Partners | Outperform |
| 2024-07-22 | アップグレード | Jefferies | Hold → Buy |
| 2024-07-18 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-10 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2024-06-27 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-05-01 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-10 | 開始されました | Barclays | Overweight |
| 2023-03-31 | 開始されました | Stephens | Overweight |
| 2023-02-02 | 開始されました | UBS | Neutral |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-08-18 | ダウングレード | Goldman | Neutral → Sell |
| 2022-07-25 | 開始されました | Canaccord Genuity | Buy |
| 2022-07-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-14 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-03-15 | 開始されました | William Blair | Outperform |
| 2020-12-02 | 開始されました | Goldman | Neutral |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-07-10 | 開始されました | Stifel | Buy |
| 2020-03-05 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-10-07 | 開始されました | BofA/Merrill | Buy |
| 2019-10-07 | 開始されました | Cowen | Outperform |
| 2019-10-07 | 開始されました | JP Morgan | Overweight |
| 2019-09-24 | 開始されました | Evercore ISI | Outperform |
すべてを表示
10 X Genomics Inc (TXG) 最新ニュース
Is 10x Genomics Inc. (1KJ) stock positioned for secular growthRecession Risk & Expert Curated Trade Ideas - mfd.ru
TXG: UBS Raises Price Target for 10x Genomics to $20 | TXG Stock News - GuruFocus
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference - BioSpace
5 Must-Read Analyst Questions From 10x Genomics's Q4 Earnings Call - Finviz
GSA Capital Partners LLP Buys 106,167 Shares of 10x Genomics $TXG - MarketBeat
162,202 Shares in 10x Genomics $TXG Bought by Principal Financial Group Inc. - MarketBeat
10x Genomics Stock Climbs as Analysts Signal Growth Prospects - StocksToTrade
10x Genomics’ Growth Prospects Brightened by Strategic Advances - timothysykes.com
10x Genomics Cancer Alliances Test AI Ambitions Against Mixed Share Performance - Yahoo Finance
10x Genomics Sees Bullish Momentum Following Revenue Projections and Price Target Upgrades - StocksToTrade
10x Genomics Sees Bullish Momentum with Raised Price Targets - timothysykes.com
Is 10x Genomics Inc. still a buy after recent gains2025 Biggest Moves & AI Forecast Swing Trade Picks - mfd.ru
Decoding 10x Genomics Inc (TXG): A Strategic SWOT Insight - GuruFocus
Earnings Call Summary | 10x Genomics(TXG.US) Q4 2025 Earnings Conference - 富途牛牛
Expert Outlook: 10x Genomics Through The Eyes Of 10 Analysts - Benzinga
10X Genomics stock price target raised to $22 from $20 at Canaccord Genuity - Investing.com UK
Why Is 10x Genomics (TXG) Stock Soaring Today - Finviz
10X Genomics stock price target raised to $22 from $20 at Canaccord Genuity By Investing.com - Investing.com India
10x Genomics (NASDAQ:TXG) Shares Gap Up on Earnings Beat - MarketBeat
10x Genomics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
10x Genomics, Inc. (NASDAQ:TXG) Q4 2025 Earnings Call Transcript - Insider Monkey
10x Genomics Q4 Earnings Call Highlights - MarketBeat
10x Genomics, Inc. SEC 10-K Report - TradingView
10x Genomics: Fourth Quarter Financial Overview - Bitget
10x Genomics Inc (TXG) Q4 2025 Earnings Call Highlights: Surpass - GuruFocus
Can 10x Genomics Inc. stock outperform in a bear market2025 Top Decliners & High Return Trade Opportunity Guides - mfd.ru
10x Genomics (TXG) Q4 2025 Earnings Transcript - AOL.com
10x Genomics (TXG) Surpasses Q4 Revenue Expectations - GuruFocus
Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
Earnings call transcript: 10x Genomics beats Q4 2025 EPS forecast By Investing.com - Investing.com India
Earnings call transcript: 10x Genomics beats Q4 2025 EPS forecast - Investing.com
10x Genomics (NASDAQ:TXG) Delivers Impressive Q4 CY2025 - Finviz
10x Genomics (TXG) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
10x Genomics Q4 2025 Financial Results: Loss Narrows, Revenue at $166MNews and Statistics - IndexBox
10x Genomics Q4 Loss Narrows, Revenue Rises; 2026 Guidance Set - marketscreener.com
10x Genomics (NASDAQ:TXG) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
10x Genomics: Q4 Earnings Snapshot - kare11.com
Earnings Flash (TXG) 10x Genomics, Inc. Reports Q4 Revenue $166.0M, vs. FactSet Est of $159.7M - marketscreener.com
10x Genomics Earnings Report: Q4 Overview - Benzinga
10x Genomics (NASDAQ: TXG) narrows 2025 losses and guides to modest 2026 growth - Stock Titan
10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 - PR Newswire
10X Genomics faces earnings test as new pricing strategy debuts By Investing.com - Investing.com South Africa
10X Genomics faces earnings test as new pricing strategy debuts - Investing.com
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Finansavisen
What makes 10x Genomics Inc. stock attractive todayQuarterly Profit Report & Free Community Consensus Stock Picks - mfd.ru
10x Genomics Earnings Preview - Sahm
10x Genomics Earnings Preview: Revenue Forecast, Analyst Estimates & Stock OutlookNews and Statistics - IndexBox
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect - Finviz
10x Genomics gets injunction against Parse Biosciences' ATAC Products - MSN
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN
IQ EQ FUND MANAGEMENT IRELAND Ltd Buys 190,059 Shares of 10x Genomics $TXG - MarketBeat
10 X Genomics Inc (TXG) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):